Clinical Trials · NCT00697463

Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women

CompletedPhase 2/Phase 3Teriparatide (Approved)
Phase
Phase 2/Phase 3
Recruitment status
Completed
Sponsor
Columbia University
Enrollment
22
Start date
Aug 2008
Locations
2 sites, United States
Primary endpoint
Change in Lumbar Spine Bone Density by Dual Energy X-ray Absorptiometry (DXA)
View Teriparatide compound reference